Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-09 · accession 0001219036-21-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-10-12 | 2021-10-09 | MYGN | LANCHBURY JERRY S | CSO | F - Tax | $30.88 | -10.8K | 264.3K | -4% | -$333.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-09 | F | D | 4,341 | $30.88 | 270,794 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-09 | F | D | 6,470 | $30.88 | 264,324 | D | — | — |